Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce rectal pain, growth failure, bloody stool, weight loss, and/or eye pain associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for 2 to 17 years old to join a Crohn’s disease clinical research study to help us discover more about treating Crohn’s and UC. If you are looking for a potential new treatment option for Crohn’s and UC or UC (including associated symptoms such as abdominal cramping, kidney stones, cramps, chronic fatigue and/or anemia), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing gastrointestinal disease flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce recurrent diarrhea, fever, rectal pain, frequent fevers, and/or liver disease associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for young people 2–17 years of age to join a Crohn’s disease study to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or Inflammatory bowel disease (including associated symptoms such as abdominal pain, stomach pain, cramps, chronic fatigue and/or liver disease), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce abdominal pain and cramps, blood in the stool, bloody stool, weight loss, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for child to join a Crohn’s disease (CD) clinical research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or Crohn’s (including associated symptoms such as abdominal cramping, joint pain, abdominal pain, chronic fatigue and/or eye pain), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local study is testing a potential new medication to see if it may reduce diarrhea, reduced appetite, abdominal pain, frequent fevers, and/or anemia associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children 2–17 years old to join a Crohn’s disease (CD) research study to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or IBD (including associated symptoms such as recurrent diarrhea, persistent diarrhea, constant need to poop, frequent fevers and/or eye pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local study is testing a potential new medication to see if it may reduce tiredness, unexplained weight loss, rectal pain, weight loss, and/or eye pain associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for child to join a CD medical research study to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or Inflammatory bowel disease (including associated symptoms such as chronic diarrhea, weight loss, abdominal pain, chronic fatigue and/or joint pain), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.